Literature DB >> 17193335

New glycosides from Tetracentron sinense and their cytotoxic activity.

Yi-Fen Wang1, Gou-Fang Lai, Thomas Efferth, Jian-Xin Cao, Shi-De Luo.   

Abstract

One novel neolignan (tetracentronsine; 1), one new indole alkaloid (=3-(2-hydroxyethyl)-1H-indole-5-O-beta-D-glucopyranoside; 2), and two new phenol derivatives, 3-{2-[(beta-glucopyranosyl)oxy]-4,5-(methylenedioxy)phenyl}propanoic acid (3) and methyl 3-{2-[(beta-glucopyranosyl)oxy]-4,5-(methylenedioxy)phenyl}propanoate (4), together with six known compounds were isolated from the stem bark of Tetracentron sinense. Their structures were determined by spectral analysis, including 1D- and 2D-NMR, and MS analyses. These compounds were tested for their cytotoxic activity against human leukaemia cells in vitro. Among them, compound 2, (E)-3-(4-hydroxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide (5), and maslinic acid (6) showed significant inhibitory activities against human leukaemia cells CCRF-CEM and its multidrug-resistant sub-line, CEM/ADR5000, with IC50 values in a range of 7.1 to 29.7 microM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17193335     DOI: 10.1002/cbdv.200690100

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  3 in total

1.  Maslinic acid induces apoptosis in salivary gland adenoid cystic carcinoma cells by Ca2+-evoked p38 signaling pathway.

Authors:  Dong-Mei Wu; Dan Zhao; De-Zhi Li; Dong-Yang Xu; Wen-Feng Chu; Xiao-Feng Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-29       Impact factor: 3.000

2.  Identification of Phlogacantholide C as a Novel ADAM10 Enhancer from Traditional Chinese Medicinal Plants.

Authors:  Myriam Meineck; Florian Schuck; Sara Abdelfatah; Thomas Efferth; Kristina Endres
Journal:  Medicines (Basel)       Date:  2016-12-05

3.  Molecular biology of cantharidin in cancer cells.

Authors:  Rolf Rauh; Stefan Kahl; Herbert Boechzelt; Rudolf Bauer; Bernd Kaina; Thomas Efferth
Journal:  Chin Med       Date:  2007-07-04       Impact factor: 5.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.